• Something wrong with this record ?

Antitumor effects and cytotoxicity of recombinant plant nucleases

J. Matoušek, T. Podzimek, P. Poučková, J. Stehlík, J. Škvor, J. Souček, J. Matoušek

. 2009 ; 18 (4) : 163-171.

Language English Country United States

Document type Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc12009124

Recombinant plant nucleases R-TBN1 and R-HBN1 were isolated to homogeneity and examined for their antitumor effects and cytotoxicity. Although antiproliferative effects of both recombinant nucleases were not significant on the ML-2 cell culture in vitro, the nucleases were strongly cytostatic in vivo after their administration intravenously as stabilized conjugates with polyethylene glycol (PEG). Recombinant nucleases were as effective against melanoma tumors as previously studied pine pollen (PN) and mung bean nucleases and their effects were reached at about 10 times lower concentrations compared to the use of bovine seminal RNase (BS-RNase). Because the recombinant nucleases R-HBN1 and R-TBN1 share only 67.4% amino acid identity and showed only partial immunochemical cross-reactivity, their similar anticancerogenic effects can be mainly explained by their catalytical similarity. Both recombinant nucleases showed lower degree of aspermatogenesis compared to BS-RNAse and PN nuclease. Unlike BS-RNase, aspermatogenesis induced by both recombinant nucleases could not be prevented by the homologous antibody complexes. Owing to relatively low cytotoxicity on the one hand, and high efficiency at low protein levels on the other, recombinant plant nucleases R-HBN1 and R-TBN1 appear to be stable biochemical agents that can be targeted as potential antitumor cytostatics.

000      
03398naa a2200553 a 4500
001      
bmc12009124
003      
CZ-PrNML
005      
20170927142321.0
008      
120319s2009 xxu eng||
009      
AR
040    __
$d ABA008 $a ABA008 $b cze
041    0_
$a eng
044    __
$a xxu
100    1_
$a Matoušek, Jaroslav, $d 1956- $7 jx20050815003 $u Biology Centre, Academy of Sciences of the Czech Republic v.v.i., Institute of Plant Molecular Biology, Ceske Budejovice
245    10
$a Antitumor effects and cytotoxicity of recombinant plant nucleases / $c J. Matoušek, T. Podzimek, P. Poučková, J. Stehlík, J. Škvor, J. Souček, J. Matoušek
520    9_
$a Recombinant plant nucleases R-TBN1 and R-HBN1 were isolated to homogeneity and examined for their antitumor effects and cytotoxicity. Although antiproliferative effects of both recombinant nucleases were not significant on the ML-2 cell culture in vitro, the nucleases were strongly cytostatic in vivo after their administration intravenously as stabilized conjugates with polyethylene glycol (PEG). Recombinant nucleases were as effective against melanoma tumors as previously studied pine pollen (PN) and mung bean nucleases and their effects were reached at about 10 times lower concentrations compared to the use of bovine seminal RNase (BS-RNase). Because the recombinant nucleases R-HBN1 and R-TBN1 share only 67.4% amino acid identity and showed only partial immunochemical cross-reactivity, their similar anticancerogenic effects can be mainly explained by their catalytical similarity. Both recombinant nucleases showed lower degree of aspermatogenesis compared to BS-RNAse and PN nuclease. Unlike BS-RNase, aspermatogenesis induced by both recombinant nucleases could not be prevented by the homologous antibody complexes. Owing to relatively low cytotoxicity on the one hand, and high efficiency at low protein levels on the other, recombinant plant nucleases R-HBN1 and R-TBN1 appear to be stable biochemical agents that can be targeted as potential antitumor cytostatics.
590    __
$a bohemika - dle Pubmed
650    02
$a zvířata $7 D000818
650    02
$a protinádorové látky $x farmakologie $7 D000970
650    02
$a skot $7 D002417
650    02
$a proliferace buněk $7 D049109
650    02
$a endonukleasy $x farmakologie $x genetika $7 D004720
650    02
$a glykosylace $7 D006031
650    02
$a lidé $7 D006801
650    02
$a Humulus $x enzymologie $7 D027582
650    02
$a myeloidní leukemie $x enzymologie $x patologie $x prevence a kontrola $7 D007951
650    02
$a Solanum lycopersicum $x enzymologie $7 D018551
650    02
$a mužské pohlaví $7 D008297
650    02
$a melanom $x enzymologie $x patologie $x prevence a kontrola $7 D008545
650    02
$a myši $7 D051379
650    02
$a myši nahé $7 D008819
650    02
$a rekombinantní proteiny $x farmakologie $x genetika $7 D011994
650    02
$a spermatogeneze $7 D013091
650    02
$a nádorové buňky kultivované $7 D014407
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Podzimek, Tomáš $7 xx0172035
700    1_
$a Poučková, Pavla, $d 1950- $7 jo2002102951
700    1_
$a Stehlik, Jan
700    1_
$a Škvor, Jiří $7 xx0098962
700    1_
$a Souček, Josef $7 xx0104682
700    1_
$a Matoušek, Josef
773    0_
$t Oncology Research $p Oncol Res $g Roč. 18, č. 4 (2009), s. 163-171 $x 0965-0407 $w MED00192851
773    0_
$p Oncol Res $g 18(4):163-71, 2009 $x 0965-0407
910    __
$a ABA008 $b x $y 4 $z 0
990    __
$a 20120319150921 $b ABA008
991    __
$a 20170927142326 $b ABA008
999    __
$a ok $b bmc $g 902348 $s 766030
BAS    __
$a 3
BMC    __
$a 2009 $b 18 $c 4 $d 163-171 $i 0965-0407 $m Oncology research $x MED00192851
LZP    __
$a 2012-1Q10/
Back

Find record

Citation metrics

Archiving options